Capstone Holding Corp. (CAPS)
CAPSNASDAQ-CMBiotechnology: Pharmaceutical Preparations
$2.09
-0.0701 (-3.25%) today
Closed, Nov 10, 4:00 PM ET
- Market cap
- $1.93m
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- –
- 52-week range
- $1.85 to $34.80
- Average volume
- 188.9k
- Previous close
- $2.16
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | $13.65m | $12.48m | $12.64m | $21.48m |
| Gross profit | $3.25m | $3.08m | $2.97m | $6.00m |
| Operating income | -$768.0k | -$8.53m | -$1.50m | $432.0k |
| Net income | -$2.01m | -$16.79m | -$1.92m | -$1.38m |
Last four quarters: revenue $60.25m, margin -36.7%, free cash flow –
News
4 latest- Capstone Holding Corp. Amends Senior Secured Convertible Note and Common Stock Purchase AgreementFintel · 1 day ago
- Capstone Holding Consensus Price Target Increased by 2,900% to $91.80Fintel · Oct 22, 2026
- Capstone Holding Corp. Announces 1-for-30 Reverse Stock SplitFintel · Oct 22, 2026
- CAPSTONE HOLDING Earnings Preview: Recent $CAPS Insider Trading, Hedge Fund Activity, and MoreQuiver Quantitative · May 7, 2025
The company
Capstone Holding Corp. (NASDAQ: CAPS) is a national, technology-enabled building products distribution platform optimizing supply chains across 38 U.S. states and Canada. Through its Instone operating platform and inventory portal, the Company aggregates and delivers proprietary stone veneer, hardscape materials, and modular masonry systems. Capstone's model combines digital infrastructure, owned-inventory logistics, and disciplined acquisitions to drive scalable margin expansion and operating leverage across its growing platform.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NASDAQ-CM
- Region
- North America
- Website
- capstoneholdingcorp.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.